文献速递心血管MR

缺血性心脏病中的心源性猝死:从影像学致心律失常基质到指导治疗

Sudden Cardiac Death in Ischemic Heart Disease: From Imaging Arrhythmogenic Substrate to Guiding Therapies.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-12-18

本文综述缺血性心脏病患者心源性猝死的影像学证据,指出当前以左心室射血分数<35%作为植入式心律转复除颤器一级预防标准,但超过80%发生心源性猝死的患者射血分数>35%。心脏磁共振可显示致心律失常心肌基质,包括瘢痕和纤维化的存在与模式,其中晚期钆增强、T1 mapping和细胞外容积分数计算等组织特征分析最具前景,并讨论影像如何指导心源性猝死预防治疗。

要点

  • 当前植入式心律转复除颤器一级预防标准为左心室射血分数<35%,但超过80%发生心源性猝死的患者射血分数>35%。
  • 心脏磁共振可显示致心律失常心肌基质,包括瘢痕和纤维化的存在与模式。
  • 晚期钆增强、T1 mapping和细胞外容积分数计算等组织特征分析是除左心室功能、应变分析和形态学外最具前景的特征。

关键影像表现/征象

  • 心脏磁共振可显示致心律失常心肌基质,包括瘢痕和纤维化的存在与模式。
  • 除左心室功能、应变分析和形态学外,最具前景的特征包括晚期钆增强、T1 mapping和细胞外容积分数计算等组织特征分析。

诊断标准与关键数值

  • 当前植入式心律转复除颤器一级预防治疗的标准为结构性心脏病伴左心室射血分数<35%。
  • 超过80%发生心源性猝死的患者左心室射血分数>35%。

临床应用与阅片要点

  • 作者认为心脏磁共振可显示致心律失常心肌基质,包括瘢痕和纤维化的存在与模式。
  • 作者认为晚期钆增强、T1 mapping和细胞外容积分数计算等组织特征分析最具前景。
  • 作者讨论影像可能指导心源性猝死预防治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Despite substantial medical advances over the past decades, sudden cardiac death (SCD) remains a leading cause of cardiovascular deaths in patients with ischemic heart disease. The presence of structural heart disease with left ventricular ejection fraction <35% is the current criteria for implantable cardioverter-defibrillator therapy as a primary prevention to SCD. However, more than 80% of patients who suffer SCD have a left ventricular ejection fraction >35%, whereas few patients who received an implantable cardioverter-defibrillator required appropriate defibrillation. Cardiac magnetic resonance enables the visualization of the arrhythmogenic myocardial substrate including the presence and pattern of scar and fibrosis. The most promising of these features, besides left ventricular function, strain analysis, and morphology, include tissue characterization using late-gadolinium enhancement, T1 mapping, and extracellular volume fraction calculation. We review the current evidence of SCD relating to ischemic heart disease, provide insights into imaging of the arrhythmogenic substrate that produces lethal ventricular arrhythmia, and discuss how imaging may guide therapies toward SCD prevention.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Gräni C, Benz DC, Gupta S, et al. Sudden Cardiac Death in Ischemic Heart Disease: From Imaging Arrhythmogenic Substrate to Guiding Therapies. JACC Cardiovasc Imaging. 2019. PMID: 31864982. doi:10.1016/j.jcmg.2019.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。